
GE HealthCare Technologies Inc. statistics
$83.02+1.44%Close 13 Nov 2026 · Market value $37.71B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
GE HealthCare Technologies Inc. is valued at $37.71B on its latest close. Its price is 17.5 times its earnings.
| Market value | $37.71B |
|---|
| Enterprise value | $45.32B |
|---|
| Price / earnings | 17.51 |
|---|
| Price / sales | 1.74 |
|---|
| Price / book | 3.25 |
|---|
| EV / EBITDA | 12.92 |
|---|
| EV / sales | 2.09 |
|---|
| Price / free cash flow | 19.96 |
|---|
| Price / free cash flow, own 5-year average | 21.89 |
|---|
| EV / EBIT | 15.67 |
|---|
| EV / free cash flow | 23.95 |
|---|
| Free cash flow yield | 5.0% |
|---|
| Dividend yield | 0.2% |
|---|
Share price
| Latest close | $83.02 |
|---|
| Day's change | +1.4% |
|---|
| 52-week high | $89.77 |
|---|
| 52-week low | $58.75 |
|---|
| From 52-week high | −7.5% |
|---|
| Return · 1 month | +19.3% |
|---|
| Return · 3 months | +12.1% |
|---|
| Return · year to date | +1.2% |
|---|
| Return · 1 year | +10.7% |
|---|
| Beta · 1 year against the S&P 500 | 0.65 |
|---|
| 50-day average | $70.55 |
|---|
| 200-day average | $69.93 |
|---|
| RSI 14 | 68.1 |
|---|
| Average volume · 20 sessions | 4.2M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 40.0% |
|---|
| Operating margin | 13.4% |
|---|
| Net margin | 10.1% |
|---|
| Free cash flow margin | 7.3% |
|---|
| Return on equity | 22.1% |
|---|
| Return on assets | 6.1% |
|---|
| Return on invested capital | 8.1% |
|---|
| Return on invested capital, 5-year average | 8.2% |
|---|
| Return on capital employed | 10.8% |
|---|
| Stock-based compensation / revenue | 0.6% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $4.49B |
|---|
| Total debt | $10.92B |
|---|
| Net debt | $6.43B |
|---|
| Current ratio | 1.37 |
|---|
| Quick ratio | 0.32 |
|---|
| Debt / equity | 1.05 |
|---|
| Net debt / EBITDA | 1.93 |
|---|
| Interest coverage | 6.28 |
|---|
Growth
| Revenue, latest quarter on a year | +7.2% |
|---|
| Revenue, twelve months on a year | +6.9% |
|---|
| EPS, latest quarter on a year | +38.8% |
|---|
| EPS, twelve months on a year | −2.3% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 458M |
|---|
| Net share repurchases | $163.0M |
|---|
| Dividends per share | $0.14 |
|---|
| Dividend payout | 3.1% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $614.0M |
|---|
| Effective tax rate | 22.2% |
|---|
GEHC in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.